Sort
8,912 grants matching “sars cov 2”
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
$1,477,970Dan H. Barouch · Beth Israel Deaconess Medical Center · U01 · FY2020 · CA
Modulating brain plasticity in rehabilitation of stroke and other brain lesions
$1,477,303Leonardo G. Cohen · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Emory Vaccine and Treatment Evaluation Unit - KidCOVE
$1,475,091Nadine Georges Rouphael · Emory University · UM1 · FY2021 · AI
Back to ECE Safely with SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers
$1,472,925Rebecca E Lee · Arizona State University-Tempe Campus · OT2 · FY2022 · HD
Human monoclonal antibodies targeting infectious pathogens
$1,466,586Joshua Hoong Yu Tan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Stanford/UNC Biomimetic U19 Research Center
$1,466,585Calvin J Kuo · Stanford University · U19 · FY2025 · AI
Mechanisms Of Humoral Evasion
$1,466,332Tongqing Zhou · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
PPG: HOST VIRUS INTERACTIONS IN HCoV-SARS INFECTIONS
$1,466,243University Of Iowa · P01 · FY2004 · AI
California National Primate Research Center
$1,459,457Prasant Mohapatra · University Of California At Davis · P51 · FY2021 · OD
International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.
$1,457,206Eliane Rohner · Universitat Bern · U01 · FY2025 · AI
Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV
$1,455,240Ralph S Baric · Univ Of North Carolina Chapel Hill · R01 · FY2017 · AI
Clinical and Informatics Research on Large Clinical Databases
$1,454,664Clement McDonald · National Library Of Medicine · ZIA · FY2024 · LM
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
$1,454,501Michel C Nussenzweig · Rockefeller University · P01 · FY2022 · AI
Scientific Core: BSL3 Virology and Animal Models
$1,454,501Charles M. Rice · Rockefeller University · P01 · FY2022 · AI
Coronavirus neutralizing antibody epitopes and immunogens
$1,454,501Paul D Bieniasz · Rockefeller University · P01 · FY2022 · AI
Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study
$1,454,407Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Protein Structure
$1,454,116Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
MFB: Better Homologous Folding using Computational Linguistics and Deep Learning
$1,453,104Liang Huang · Oregon State University · · FY2024 · CSE
Maternal SARS-CoV-2 infection, placenta biology, and neurodevelopmental outcomes in the offspring
$1,451,606Gianluca Ursini · Lieber Institute, Inc. · R01 · FY2025 · HD
Post-Viral Syndromes
$1,451,554Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
Antisense Oligonucleotide (ASO) Development for Rare and Neglected Diseases
$1,450,000Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
Core 2: Biocontainment and Immune Monitoring Core
$1,447,074Gregory D Sempowski · Duke University · P01 · FY2023 · AI
Determinants and Outcomes of Nicotine Metabolite Ratio in HIV + Smokers
$1,446,525Robert Gross · University Of Pennsylvania · R01 · FY2021 · HL
SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects
$1,446,305Pandurangan Vijayanand · La Jolla Institute For Immunology · U01 · FY2020 · CA
PPG: HOST VIRUS INTERACTIONS IN HCoV-SARS INFECTIONS
$1,445,380Stanley Perlman · University Of Iowa · P01 · FY2006 · AI